RETRACTED: Intravenous versus perineural dexmedetomidine in prolongation of analgesia with regional anesthesia: a meta-analysis and systematic review

Yan Feng,Xiao-Bo Chen,Pan Chang,Yu-Jun Zhang,Wen-Sheng Zhang,Xiao-Lin Yang

doi:10.31636/pmjua.v6i2.2

Abstract

This article has been retracted due to the copyright conflicts existing among the authors. Date: 20.08.22

Highlights

Postoperative pain, playing an important part in unpleas ant experience, negatively affects postoperative recov ery, increases hospitalization costs, and the risk of postoperative adverse events and the develop ment of chronic pain [1]
Our meta-analysis generates the evidence that perineural dexmedetomidine is a superior adminstration for prolonging the duration of analgesia
Perineural dexmedetomidine shows the advantages in duration of sensory block and the onset time of sensory and motor block, when compared to the intravenous administration

Summary

Conclusions

Our meta-analysis generates the evidence that perineural dexmedetomidine is a superior adminstration for prolonging the duration of analgesia. Perineural dexmedetomidine shows the advantages in duration of sensory block and the onset time of sensory and motor block, when compared to the intravenous administration. Dexmedetomidine as a local anesthetic adjuvant for perineural injection may be much safer than intravenous application because of the lower incidence of patients of Ramsay Sedation Scale > 3 and lower incidence of hypotension and bradycardia

Introduction

Methods

Literature search

Results

Limitations

Conclusion